We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

260 hedge funds and large institutions have $3.09B invested in Axsome Therapeutics in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 26

28% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 75

7% more funds holding

Funds holding: 244 → 260 (+16)

1% less capital invested

Capital invested by funds: $3.12B → $3.09B (-$30.4M)

1.03% less ownership

Funds ownership: 82.88% → 81.84% (-1%)

25% less call options, than puts

Call options by funds: $49.5M | Put options by funds: $66.4M

31% less funds holding in top 10

Funds holding in top 10: 13 → 9 (-4)

Holders
260
Holders Change
+16
Holders Change %
+6.56%
% of All Funds
3.75%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
45
Increased
96
Reduced
75
Closed
26
Calls
$49.5M
Puts
$66.4M
Net Calls
-$16.9M
Net Calls Change
-$54.8M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$56.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$36.7M
3
DTC
Deep Track Capital
Connecticut
+$25.6M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$23.5M
5
EAM
Eagle Asset Management
Florida
+$19M

Top Sellers

1
BI
BVF Inc
California
-$158M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$29.1M
4
TCM
Tang Capital Management
California
-$25.5M
5
Morgan Stanley
Morgan Stanley
New York
-$24.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
51
MPM BioImpact
Massachusetts
$9.11M +$1.74M +20,740 +22%
WCM Investment Management
52
WCM Investment Management
California
$8.9M +$569K +6,782 +6%
Franklin Resources
53
Franklin Resources
California
$8.61M +$8.76M +104,325 +2,942%
FCM
54
Frontier Capital Management
Massachusetts
$8.41M +$878K +10,456 +11%
TLP
55
Tri Locum Partners
New York
$8.2M -$2.35M -28,027 -21%
Walleye Capital
56
Walleye Capital
New York
$7.75M +$8.15M +97,120 New
Citigroup
57
Citigroup
New York
$7.59M -$559K -6,655 -7%
Neuberger Berman Group
58
Neuberger Berman Group
New York
$7.31M +$3.97M +47,341 +107%
ClearBridge Investments
59
ClearBridge Investments
New York
$7.13M +$7.5M +89,370 New
AGP
60
Artia Global Partners
Florida
$7.01M – – –
PCM
61
Peregrine Capital Management
Minnesota
$6.87M +$111K +1,318 +2%
LC
62
Lindbrook Capital
California
$6.68M -$26.7K -318 -0.4%
Deutsche Bank
63
Deutsche Bank
Germany
$6.63M +$275K +3,272 +4%
CS
64
Cannell & Spears
New York
$6.6M +$6.94M +82,730 New
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$6.59M +$5.29M +63,067 +324%
PFM
66
Privium Fund Management
Netherlands
$6.55M +$839K +10,000 +14%
AllianceBernstein
67
AllianceBernstein
Tennessee
$6.4M +$3.26M +38,864 +94%
AG
68
Artal Group
Luxembourg
$6.13M +$6.45M +76,837 New
CS
69
Candriam SCA
Luxembourg
$5.99M -$839K -10,000 -12%
HWAM
70
Hennion & Walsh Asset Management
New Jersey
$5.54M +$744K +8,867 +15%
ACM
71
Atika Capital Management
New York
$5.43M +$109K +1,300 +2%
MAP
72
Moody Aldrich Partners
Massachusetts
$5.24M -$101K -1,207 -2%
First Trust Advisors
73
First Trust Advisors
Illinois
$5.23M -$369K -4,397 -6%
SA
74
SpiderRock Advisors
Delaware
$5.08M +$5.88M +70,019 New
William Blair & Company
75
William Blair & Company
Illinois
$5.07M +$4.62M +55,027 +646%
1 2
3
4 5

AXSM Hedge Fund Activity: Q1 2024 in Review

260 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q1 2024, worth a combined $3.09B — down 0.98% from $3.12B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new AXSM positions and 26 closed out — a net gain of 19 holders — while 96 added to existing stakes and 75 trimmed.

The largest buyer was Macquarie Group, adding an estimated $56.5M. The largest seller was BVF Inc, exiting entirely with an estimated $158M sold.

  • 260 institutional investors held Axsome Therapeutics (AXSM) as of Q1 2024, up from 244 in Q4 2023.
  • Funds reported $3.09B of Axsome Therapeutics stock for Q1 2024, down 0.98% quarter-over-quarter.
  • 45 funds opened new Axsome Therapeutics positions in Q1 2024 and 26 closed out, a net change of +19 holders.
  • The largest Axsome Therapeutics buyer in Q1 2024 was Macquarie Group, an estimated $56.5M added.
  • The largest Axsome Therapeutics seller in Q1 2024 was BVF Inc, an estimated $158M sold.

Based on aggregated 13F filings for Q1 2024.